Skp2 p45 Activators, a group of chemical compounds that are capable of influencing the activity or function of the Skp2 p45 protein. Skp2 p45, also known as S-phase kinase-associated protein 2, plays a critical role in the regulation of the cell cycle and cell proliferation. It is a component of the Skp1-Cullin1-F-box (SCF) ubiquitin ligase complex, which is responsible for targeting specific proteins for degradation by the proteasome. Skp2 p45 is particularly involved in the ubiquitination and subsequent degradation of cell cycle inhibitors, such as p27 and p21, thereby promoting cell cycle progression and cell division.
The activation of Skp2 p45 through specific chemical compounds might involve modulating its interaction with other components of the SCF complex or altering its substrate specificity. This could result in enhanced ubiquitination and degradation of cell cycle inhibitors, ultimately leading to increased cell cycle progression. The mechanism of action of Skp2 p45 Activators might involve binding to Skp2 p45 or its associated regulatory proteins, triggering conformational changes that enhance its ubiquitin ligase activity. By influencing Skp2 p45 activity, these compounds impact cell cycle regulation, cell proliferation, and possibly cellular responses to various stimuli.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Modulates gene expression through estrogen receptors, potentially affecting SKP2 p45 via downstream signaling or estrogen response elements. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
Impacts gene expression via the vitamin D receptor, potentially influencing SKP2 p45 through vitamin D response elements or related pathways. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Affects various cellular processes and signaling pathways, potentially influencing SKP2 p45 expression via intersecting signaling cascades. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Modulates gene expression through retinoic acid receptors, potentially affecting SKP2 p45 expression as part of differentiation or related pathways. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Inhibits topoisomerases, affecting DNA replication and repair, which might indirectly influence SKP2 p45 expression through cell cycle disruption. | ||||||
ERK Inhibitor Inhibitor | 1049738-54-6 | sc-221593 | 5 mg | $137.00 | 6 | |
This compound activates PPARγ, impacting gene expression, and potentially influencing SKP2 p45 expression through PPARγ-mediated pathways. | ||||||
PGD2 (Prostaglandin D2) | 41598-07-6 | sc-201221 sc-201221A | 1 mg 10 mg | $96.00 $583.00 | 4 | |
Participates in diverse physiological processes and signaling pathways that could intersect with cell cycle regulation, influencing SKP2 p45 expression. | ||||||
Baicalein | 491-67-8 | sc-200494 sc-200494A sc-200494B sc-200494C | 10 mg 100 mg 500 mg 1 g | $32.00 $42.00 $162.00 $292.00 | 12 | |
Exhibits antioxidant and anti-inflammatory properties, potentially affecting SKP2 p45 expression through modulation of relevant signaling pathways. | ||||||